Take the next step with GEBT, a new alternative for conducting gastric emptying studies.

GEBT can be administered at a patient’s home via Telehealth or in a clinical setting.

Cairn Diagnostics developed the Spirulina Gastric Emptying Breath Test (GEBT) to evaluate the rate of solid phase gastric emptying and aid in diagnosing gastroparesis.

GEBT is a safe, standardized, non-radioactive and FDA-approved alternative to nuclear medicine-based gastric emptying evaluations conducted in a nuclear medicine center.

Gastroparesis is a condition where food empties too slowly from the stomach. Symptoms of gastroparesis include nausea, vomiting, feeling full after only a few bites of food, upper abdominal pain, bloating and lack of appetite. Gastroparesis can cause weight loss, malnutrition and dehydration. This condition can be especially problematic for individuals with diabetes because it adversely affects glycemic control. Over 5 million people suffer from gastroparesis.

GEBT, the first gastroparesis test at home. The test can be conducted in clinicians’ offices, research centers or at the patient’s home by virtual telehealth.

Cairn Diagnostics is a specialized, innovative life sciences company focused on developing novel breath tests intended for routine use in diagnostic medicine. At Cairn Diagnostics, our mission is to develop tests that eliminate complexity and create a safer, faster and clearer path to diagnosis.